tiprankstipranks
Trending News
More News >
Immunome (IMNM)
NASDAQ:IMNM
US Market
Advertisement

Immunome (IMNM) Financial Statements

Compare
337 Followers

Immunome Financial Overview

Immunome's market cap is currently $987.09M. The company's EPS TTM is $-0.5; its P/E ratio is ―; Immunome is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $-0.57. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Immunome Earnings and Revenue History

Immunome Debt to Assets

Immunome Cash Flow

Immunome Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis